CRISPR

CRISPR3-surf1

ID
ZDB-CRISPR-231108-15
Name
CRISPR3-surf1
Previous Names
None
Target
Sequence
5' - CACTCTACAGGCAGTGGGATTGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
cri2 surf1
Expression
Gene expression in Wild Types + CRISPR3-surf1
No data available
Phenotype
Phenotype resulting from CRISPR3-surf1
No data available
Phenotype of all Fish created by or utilizing CRISPR3-surf1
Phenotype Fish Conditions Figures
brain opaque, ameliorated surf1cri2/cri2 chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
brain transparent, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
swimming behavior decreased process quality, exacerbated surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 5 from Haroon et al., 2023
swimming behavior decreased process quality, abnormal surf1cri2/cri2 standard conditions Fig. 3Fig. 5 from Haroon et al., 2023
heart contraction decreased process quality, exacerbated surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 5 from Haroon et al., 2023
glutathione metabolic process decreased process quality, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
heart contraction process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
thigmotaxis process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
reactive oxygen species biosynthetic process rate, ameliorated surf1cri2/cri2 chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
thigmotaxis decreased process quality, exacerbated surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 5 from Haroon et al., 2023
regulation of cytochrome-c oxidase activity decreased process quality, abnormal surf1cri2/cri2 standard conditions Fig. 2 from Haroon et al., 2023
regulation of cytochrome-c oxidase activity decreased process quality, abnormal surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
reactive oxygen species biosynthetic process rate, ameliorated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
whole organism Ab4-cox4 labeling decreased amount, abnormal surf1cri2/cri2 standard conditions Fig. 2 from Haroon et al., 2023
thigmotaxis decreased process quality, abnormal surf1cri2/cri2 standard conditions Fig. 5 from Haroon et al., 2023
heart contraction decreased process quality, abnormal surf1cri2/cri2 standard conditions Fig. 5 from Haroon et al., 2023
swimming behavior decreased process quality, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
lactate biosynthetic process increased rate, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
lactate biosynthetic process increased rate, exacerbated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
brain transparent, exacerbated surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 5 from Haroon et al., 2023
heart contraction decreased process quality, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
swimming behavior process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
glutathione metabolic process process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
thigmotaxis decreased process quality, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
brain opaque, ameliorated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
swimming behavior process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
thigmotaxis process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
brain transparent, abnormal surf1cri2/cri2 standard conditions Fig. 5 from Haroon et al., 2023
heart contraction process quality, ameliorated surf1cri2/cri2 chemical treatment by environment: cysteamine bitartrate, chemical treatment by environment: sodium azide Fig. 6 from Haroon et al., 2023
reactive oxygen species biosynthetic process increased rate, abnormal surf1cri2/cri2 chemical treatment by environment: sodium azide Fig. 7 from Haroon et al., 2023
Citations